UAE’s Mubadala acquires full ownership of UCB Pharma’s China business with CBC GroupValue of transaction is expected to close in fourth quarter of 2024Deal includes UCB’s neurology and allergy portfoliosBy Miguel Hadchity · 26 August 2024
